Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Montine

Showing results (1-10 of 471) with videos related to

Pageof 48
Sort By:
Brain Pathology (Zurich, Switzerland)|June 5, 2010
Cognitive impairment in Parkinson's diseaseThomas J Montine
Toxicologic Pathology|December 24, 2010
Prevalence estimates for latent neurodegenerative diseaseThomas J Montine
Nature Reviews. Neurology|May 11, 2011
Parkinson disease: PD biomarkers-use of α-synuclein reaches new levelsThomas J Montine
Journal of Graduate Medical Education|July 12, 2024
Guidance for a Career in an Academic Medical CenterThomas J Montine
Biomarkers in Medicine|April 13, 2010
Biomarkers of oxidative damage and inflammation in Alzheimer's diseaseDouglas Galasko, Thomas J Montine
Annals of Neurology|March 16, 2007
Proteomic discovery of CSF biomarkers for Alzheimer's diseaseJing Zhang, Thomas J Montine
Archives of Pathology & Laboratory Medicine|February 7, 2008
Multiplex immunoassay analysis of cytokines in idiopathic inflammatory myopathyGeoffrey S Baird, Thomas J Montine
JAMA|December 17, 2009
Late-life dementias: does this unyielding global challenge require a broader view?Thomas J Montine, Eric B Larson
Journal of Alzheimer'S Disease : JAD|June 16, 2012
Anatomic and clinical pathology of cognitive impairment and dementiaKathleen S Montine, Thomas J Montine
The American Journal of Pathology|April 28, 2005
Fatty acid oxidation in the pathogenesis of Alzheimer's diseaseThomas J Montine, Jason D Morrow
Pageof 48

Showing results (1-10 of 471) with videos related to

Sort By:
Pageof 48
Brain Pathology (Zurich, Switzerland)|June 5, 2010
Cognitive impairment in Parkinson's diseaseThomas J Montine
Toxicologic Pathology|December 24, 2010
Prevalence estimates for latent neurodegenerative diseaseThomas J Montine
Nature Reviews. Neurology|May 11, 2011
Parkinson disease: PD biomarkers-use of α-synuclein reaches new levelsThomas J Montine
Journal of Graduate Medical Education|July 12, 2024
Guidance for a Career in an Academic Medical CenterThomas J Montine
Biomarkers in Medicine|April 13, 2010
Biomarkers of oxidative damage and inflammation in Alzheimer's diseaseDouglas Galasko, Thomas J Montine
Annals of Neurology|March 16, 2007
Proteomic discovery of CSF biomarkers for Alzheimer's diseaseJing Zhang, Thomas J Montine
Archives of Pathology & Laboratory Medicine|February 7, 2008
Multiplex immunoassay analysis of cytokines in idiopathic inflammatory myopathyGeoffrey S Baird, Thomas J Montine
JAMA|December 17, 2009
Late-life dementias: does this unyielding global challenge require a broader view?Thomas J Montine, Eric B Larson
Journal of Alzheimer'S Disease : JAD|June 16, 2012
Anatomic and clinical pathology of cognitive impairment and dementiaKathleen S Montine, Thomas J Montine
The American Journal of Pathology|April 28, 2005
Fatty acid oxidation in the pathogenesis of Alzheimer's diseaseThomas J Montine, Jason D Morrow
Pageof 48